Cancer incidence rates among the young has increased drastically in the MENA region. An alarming outcome, which indicates the requirement of focused research to address potential risk factors. Although developed MENA countries have shown promising health outcomes, the same cannot be said about developing countries in the region. Overall, Cancer is the third leading cause of death in the region. The MENA Cancer Care Summit, will be an exclusive 2-day virtual event, which will include strategic deliberations on the whole oncology eco system. The event will focus on recent advances, current challenges and emerging therapies in the cancer care spectrum. The event will have an inclusive approach towards understanding the importance of technology & research in early detection, clinical approaches, prevention and control. The MENA Cancer Care Summit, will be a great opportunity for healthcare authorities, healthcare professionals, researchers, academics and cancer control officials from the region to engage and discuss on mitigating the effects of cancer.

Benefits Of Attending

  • Understand effective and targeted therapy models for oncology and their impact
  • Hear from global experts on methods to diagnose critical care patients and digitization of care delivery
  • Learn about emerging technologies which will revolutionize cancer detection, treatment & control
  • Identify regional cancer incidence burden and benchmark infrastructure needs to tackle the problem
  • Hear from oncology experts from around the world about diagnostic & therapeutic best practices in the cancer care continuum
  • Network with regional and global thought leaders, scientists, healthcare professionals and authorities
  • Explore new solutions, technologies and services which will further improve quality of life and cancer treatment protocols

    Current Trends

  • Highest Cancer Mortality Rate – An estimated 108 people died from cancer per 100,000 of the population in Egypt last year
  • Saudi Cancer Incidence Rate – 39% among the age group 20 – 49 years
  • UAE Cancer Incidence Rate – 37% among the age group 20 – 49 years
  • GCC estimated Oncology market size to reach $5.1 billion by 2027, growing at a CAGR of 11.2% between 2022-2027
  • Chemotherapy segment is estimated to grow with the fastest CAGR of 12.1% during the forecast period 2022-2027
  • Regional Oncology Information system market estimated to grow at CAGR 7.08% valued at $ 286.42 million by 2027

Cancer Immunotherapy market pegged to grow at a CAGR of 11.35% from 2022-2027. Predicted to be worth $9.21 billion by 2027

Key Themes

  • Cancer Genetics & Genomics
  • Cancer Immunotherapy & Vaccines
  • The Future of Cancer Research
  • Cancer Drugs Advancements
  • Oncology Infrastructure
  • Emerging Cancer Detection Trends
  • Epidemiology, Statistics & Health Outcomes
  • Recent Trends in Cancer Therapy
  • Technologies & Innovations in Cancer Care & Treatment

Related Articles

Back to top button